Warfarin-related intracerebral haemorrhage: better outcomes when reversal includes prothrombin complex concentrates

作者: H. C. Hanger , J. A. A. Geddes , T. J. Wilkinson , M. Lee , A. E. Baker

DOI: 10.1111/IMJ.12034

关键词:

摘要: Background Warfarin-related intracerebral haemorrhage (WRICH) has high mortality. Haematoma expansion is prolonged in WRICH and independently predicts worse outcomes. Guidelines recommend prompt reversal of the warfarin coagulopathy, but evidence benefit lacking. Aims To determine whether introduction a protocol (late 2008), which includes prothrombin complex concentrates (PCC), improves outcomes Methods All patients presenting with between January 2004 July 2010 were included. Retrospective case note radiology review was performed, collecting data on (ICH) severity, degree timeliness reversal, patient Cox's proportional hazards analysis used to compare outcomes associated without PCC after controlling for ICH severity. Results Eighty-eight included (27 treated palliatively). Mean international normalised ratio 2.9. Vitamin K, fresh frozen plasma given alone or combination 68, 23 44 patients, mean time from computed tomography scanning administration 2.2, 3.3 3.1 h respectively. Four received pre-protocol (none before 2007), two during development seventeen post-protocol. Those who had improved survival (P < 0.001). After score, hazard death 0.27 0.01) use PCC. Survival tended be greater earlier = 0.053). Despite survival, discharge domicile function not significantly worse. Conclusions PCC worsened disability. Delays may have reduced potential benefits.

参考文章(36)
H. Tran, M. Collecutt, S. Whitehead, H. H. Salem, Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation. Internal Medicine Journal. ,vol. 41, pp. 337- 343 ,(2011) , 10.1111/J.1445-5994.2010.02237.X
Chiara Marchesi, Matteo Pierfranceschi, Mark Crowther, David Garcia, Elaine Hylek, Daniel Witt, Nathan Clark, Alessandro Squizzato, Davide Imberti, Walter Ageno, Francesco Dentali, Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists Thrombosis and Haemostasis. ,vol. 106, pp. 429- 438 ,(2011) , 10.1160/TH11-01-0052
J P Broderick, T G Brott, J E Duldner, T Tomsick, G Huster, Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. ,vol. 24, pp. 987- 993 ,(1993) , 10.1161/01.STR.24.7.987
Nicholas M. Boulis, Miroslav P. Bobek, Alvin Schmaier, Julian T. Hoff, Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery. ,vol. 45, pp. 1113- 1119 ,(1999) , 10.1097/00006123-199911000-00020
Matthew Flaherty, Anticoagulant-associated intracerebral hemorrhage. Seminars in Neurology. ,vol. 30, pp. 565- 572 ,(2010) , 10.1055/S-0030-1268866
Juha Huhtakangas, Sami Tetri, Seppo Juvela, Pertti Saloheimo, Michaela K. Bode, Matti Hillbom, Effect of Increased Warfarin Use on Warfarin-Related Cerebral Hemorrhage A Longitudinal Population-Based Study Stroke. ,vol. 42, pp. 2431- 2435 ,(2011) , 10.1161/STROKEAHA.111.615260
Cindy A. Leissinger, Philip M. Blatt, W. Keith Hoots, Bruce Ewenstein, Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. American Journal of Hematology. ,vol. 83, pp. 137- 143 ,(2008) , 10.1002/AJH.21046
J.-Ph. Neau, C. Couderq, P. Ingrand, P. Blanchon, R. Gil, Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovascular Diseases. ,vol. 11, pp. 195- 200 ,(2001) , 10.1159/000047638
L. Sjoblom, H.-G. Hardemark, A. Lindgren, B. Norrving, M. Fahlen, M. Samuelsson, L. Stigendal, D. Stockelberg, A. Taghavi, L. Wallrup, J. Wallvik, Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy A Swedish Multicenter Study Stroke. ,vol. 32, pp. 2567- 2574 ,(2001) , 10.1161/HS1101.098523